Active Pharmaceutical Ingredients (API) Market : In 2014 - 2020, Industry Size, Shares, Research Trends and Growth

Active Pharmaceutical Ingredients (API) Market : In 2014 - 2020,
Industry Size, Shares, Research Trends and Growth
Report Description
This report analyses the global market for active pharmaceutical
ingredients for the period from 2012 to 2020. The market has been
analyzed on the basis of type of API manufacturing (captive or inhouse
and contract manufacturing), type of active pharmaceutical
ingredients (synthetic chemical API and biological API), type of drugs

(branded or innovative prescription drugs, generic prescription drugs,
and over-the-counter drugs), therapeutic areas, and by geography.
The global API market is analyzed on the basis of therapeutic areas
namely, NSAIDs, oncology drugs, diabetes drugs, cardiovascular
drugs, central nervous system drugs, musculoskeletal drugs, and other
drugs (such as antibacterial, antiviral, antifungal drugs, etc.). Also, the
market for select NSAIDs (paracetamol, ibuprofen, aspirin, and
naproxen) has alsbeen analyzed in detail in this report. The above
mentioned segments are analyzed on the basis of market size in terms
of USD million and their forecasts for the period 2014 to 2020 have
alsbeen provided. The CAGR (%) for the segments have been
estimated for the forecast period from 2014 to 2020, considering 2013
as the base year.
The study is a robust combination of primary and secondary research.
Primary research formed the bulk of our research efforts with
information collected from telephonic interviews and interactions via e-
mails. Secondary research involved study of company websites,
annual reports, press releases, stock analysis presentations, and

various international and national databases. The report provides
market size in terms of USD million for each segment for the period
from 2012 to 2020, considering the macrand micrenvironmental
factors. Growth rates for each segment within the global API market
have been determined after a thorough analysis of past trends,
demographics, future trends, technological developments, and
regulatory requirements.
Read Complete Report @ http://www.mrrse.com/activepharmaceutical-ingredients
Geographically, the global API market has been segmented intfour
regions including North America, Europe, Asia Pacific and Rest of the
World (RoW). Market sizes, forecasts and % CAGR for each region
have been provided. A qualitative analysis of the market dynamics of
the global active pharmaceutical ingredients market, which are
responsible for driving or restraining the growth of this market, along
with market opportunities has been described in the market overview
section of this report. The report alsprovides insights intselect NSAIDs

namely, paracetamol, ibuprofen, naproxen, and aspirin in terms of
volume and revenue for the period 2012 to 2020.
The competitive landscape section of the report includes market share
analysis in terms of revenue by significant players operating in the
global API market for 2013. The study further provides Porter’s five
force analysis, market attractiveness analysis, and recommendations
which would be useful for existing and new players tsustain and
increase market share in the global active pharmaceutical ingredients
market. This report concludes with the company profiles section in
which major players in the global API market have been profiled based
on various attributes such as company overview, financial overview,
product portfolio, business strategies and recent/key developments in
the market. The global API market is highly fragmented with more than
2,500 players. Key companies profiled in the report include Boehringer
Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories,
Ltd., BASF SE, Hospira, Inc., Lonza Group, Mylan, Inc., Novartis AG,
Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Actavis plc, and Wuxi
Apptec.

Enquiry For This Report @ http://www.mrrse.com/enquiry/1010
The global active pharmaceutical ingredients market is segmented as
follows:
Active Pharmaceutical Ingredients Market, by Type of
Manufacturing
• Captive or In-house API manufacturing
• API contract manufacturing
Active Pharmaceutical Ingredients Market, by Type of API
• Synthetic Chemical API
• Biological API

Active Pharmaceutical Ingredients Market, by Type of Drug
• Branded or Innovative Prescription Drugs
• Generic Prescription Drugs
• Over-the-counter Drugs
Active Pharmaceutical Ingredients Market, by Therapeutic Area
• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Oncology Drugs
• Anti-diabetic Drugs
• Cardiovascular Drugs
• Central Nervous System Drugs
• Musculoskeletal Drugs
• Other Drugs (antibacterial, antiviral, antifungal, etc.)
Request a Sample Copy of the Report @
http://www.mrrse.com/sample/1010

Active Pharmaceutical Ingredients Market, by Geography
• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)
Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global API Market (2013 & 2020)
2.2 Comparative Analysis: Global API Market Revenue, by Geography,
2013 & 2020 (Value %)
2.3 Global API Market Revenue, by Therapeutic Area, 2013 (USD
Million)

About MRRSE
MRRSE stands for Market Research Reports Search Engine, the
largest online catalog of latest market research reports based on
industries, companies, and countries. MRRSE sources thousands of
industry reports, market statistics, and company profiles from trusted
entities and makes them available at a click. Besides well-known
private publishers, the reports featured on MRRSE typically come from
national statistics agencies, investment agencies, leading media
houses, trade unions, governments, and embassies.

Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
http://www.mrrse.com/
Email: sales@mrrse.com